Free Trial
NASDAQ:SBRA

Sabra Healthcare REIT Q3 2026 Earnings Date & Estimates

Sabra Healthcare REIT logo
$18.96 +0.12 (+0.64%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$19.03 +0.07 (+0.37%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sabra Healthcare REIT is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:00 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:00 PM ET

What Analysts Expect from Sabra Healthcare REIT in Q3 2026

Sabra Healthcare REIT is expected to post earnings of $0.1674 per share on revenue of $233.99 million. In the same quarter a year earlier Sabra Healthcare REIT reported $0.38 per share on revenue of $190.04 million. Sabra Healthcare REIT last reported on August 3, 2026, posting -$0.10 per share and missing the $0.1711 consensus estimate. Sabra Healthcare REIT has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.1674
Expected Revenue
$233.99 million
Prior-Year EPS
$0.38
Prior-Year Revenue
$190.04 million
Expected EPS Growth
-55.9%
Expected Revenue Growth
+23.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.10 (Missed by -$0.2711)
Last Quarter Revenue
$230.11 million
EPS Beat Rate
3 of last 8 quarters

Sabra Healthcare REIT Q3 2026 Earnings FAQ

Sabra Healthcare REIT (NASDAQ:SBRA) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes.

Sabra Healthcare REIT's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Sabra Healthcare REIT to post earnings of $0.1674 per share for Q3 2026.

The consensus revenue estimate for Sabra Healthcare REIT is $233.99 million for Q3 2026.

Sabra Healthcare REIT Earnings Headlines

Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.tc pixel
Barclays Remains a Hold on Sabra Healthcare REIT (SBRA)
See More Sabra Healthcare REIT Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sabra Healthcare REIT? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sabra Healthcare REIT and other key companies, straight to your email.

About Sabra Healthcare REIT

Sabra Healthcare REIT (NASDAQ:SBRA) is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company primarily provides capital to healthcare operators through property ownership, leases, mortgage loans, and other investment structures.

Sabra’s portfolio has historically included skilled nursing facilities, senior housing communities, behavioral health facilities, specialty hospitals, and other healthcare properties. Its properties are generally leased to or operated by third-party healthcare providers, allowing the company to participate in the healthcare real estate market without directly delivering most patient-care services.

Founded in 2010, Sabra Healthcare REIT serves healthcare markets primarily in the United States, with investments that have also included select properties in Canada. The company is headquartered in Irvine, California, and is led by Richard K. Matros, who serves as chief executive officer and chairman.

View Sabra Healthcare REIT Profile